Abstract
The hepatitis viruses, named A–E, cause acute and chronic liver disease depending on the virus. Laboratory-based diagnosis relies on the detection of specific markers of infection for each virus, through the use of appropriate serological tests. In recent years, molecular tests that rely on the amplification of viral nucleic acids have also been employed, not only in confirming active viral replication but also in monitoring antiviral treatment efficacy. Some of these tests that are currently in use in routine diagnostic laboratories are outlined in this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Karayiannis, P., Main, J., and Thomas, H.C. (2004) Hepatitis vaccines. Br Med Bull 70, 29–49.
Nainan, O.V., Xia, G., Vaughan, G., and Margolis, H.S. (2006) Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev 19, 63–79.
Costa-Mattioli, M., Di Napoli, A., Ferré, V., Billaudel, S., Perez-Bercoff, R., and Cristina, J. Genetic variability of hepatitis A virus. J Gen Virol 84, 3191–3201.
Ping, L.H., Jansen, R.W., Stapleton, J.T., Cohen, J.I., and Lemon, S.M. (1988) Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proc Natl Acad Sci USA 85, 8281–8285.
Ganem, D. and Prince, A.M. (2004) Hepatitis B virus infection – natural history and clinical consequences. N Engl J Med 350, 118–129.
Karayiannis, P., Carman, W.F., and Thomas, H.C. (2005) Molecular variations in the core promoter, precore and core regions of hepatitis B virus, and their clinical significance. In: Thomas, H.C., Lemon, S., and Zuckerman, A.J. Ed. Viral Hepatitis. Blackwell, London, pp. 242–262.
Lok, A.S. (2007) Navigating the maze of hepatitis B treatments. Gastroenterology 132, 1586–1594.
Carman, W.F., Jazayeri, M., Basune, A., Thomas, H.C., and Karayiannis, P. (2005) Hepatitis B surface antigen (HBsAg) variants. In: Thomas, H.C., Lemon, S., and Zuckerman, A.J. Ed. Viral Hepatitis. Blackwell, London, pp. 225–241.
Moradpour, D., Penin, F., and Rice, C.M. (2007) Replication of hepatitis C virus. Nat Rev Microbiol 5, 453–463.
Foster, G. and Mathurin, P. (2008) Hepatitis C virus therapy to date. Antivir Ther 13(Suppl 1), 3–8.
Simmonds, P., Bukh, J., Combet, C., Deléage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspé, G., Kuiken, C., Maertens, G., Mizokami, M., Murphy, D.G., Okamoto, H., Pawlotsky, J.M., Penin, F., Sablon, E., Shin-I, T., Stuyver, L.J., Thiel, H.J., Viazov, S., Weiner, A.J., and Widell, A. (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42, 962–973.
Taylor, J.M. (2006) Hepatitis delta virus. Virology 344, 71–76.
Dény P. (2006) Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? Curr Top Microbiol Immunol 307, 151–171.
Mushahwar, I.K. (2008) Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 80, 646–658.
Okamoto H. (2007) Genetic variability and evolution of hepatitis E virus. Virus Res 127, 216–228.
Karayiannis, P., Alexopoulou, A., Hadziyannis, S., Thursz, M., Watts, R., Seito, S., and Thomas, H.C. (1995) Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology 22, 1628–1634.
Carman, W.F., Jacyna, M.R., Hadziyannis, S., Karayiannis, P., McGarvey, M., Makris, A., and Thomas, H.C. (1989) Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet ii, 588–591.
Carman, W.F., Zanetti, A.R., Karayiannis, P., Manzillo, G., Tanzi, E., Zuckerman, A.J., and Thomas, H.C. (1990) A vaccine induced escape mutant of hepatitis B virus. Lancet ii, 325–329.
Seddigh-Tonekaboni, S., Waters, J.A., Jeffers, S., Gehrke, R., Ofenloch, B., Horsch, A., Hess, G., Thomas, H.C., and Karayiannis, P. (2000) The effect of variation in the common “a” determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60, 113–121.
Yamashiro, T., Nagayama, K., Enomoto, N., Watanabe, H., Miyagi, T., Nakasone, H., Sakugawa, H., and Watanabe, M. (2004) Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction – and its possible correlation with the clinical stage of liver disease. J Infect Dis 189, 1151–1157.
Gyarmati, P., Mohammed, N., Norder, H., Blomberg, J., Belák, S., and Widén, F. (2007) Universal detection of hepatitis E virus by two real-time PCR assays: TaqMan and primer-probe energy transfer. J Virol Methods 146, 226–235.
Sarrazin, C. (2002) Highly sensitive hepatitis C virus RNA detection methods: molecular backgrounds and clinical significance. J Clin Virol 25(Suppl 3), 23–29.
Bartholomeusz, A. and Locarnini, S.A. (2006) Antiviral drug resistance: clinical consequences and molecular aspects. Semin Liver Dis 26, 162–170.
Jensen, D.M. and Ascione, A. (2008) Future directions in therapy for chronic hepatitis C. Antivir Ther 3(Suppl 1), 31–36.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Karayiannis, P. (2010). The Detection of Hepatitis Viruses. In: Stephenson, J., Warnes, A. (eds) Diagnostic Virology Protocols. Methods in Molecular Biology, vol 665. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-817-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-60761-817-1_6
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-816-4
Online ISBN: 978-1-60761-817-1
eBook Packages: Springer Protocols